- Home
- CMPX vs PCF Comparison
CMPX vs PCF Comparison
Compare CMPX & PCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- PCF
- Stock Information
- Founded
- CMPX 2014
- PCF 1987
- Country
- CMPX United States
- PCF United States
- Employees
- CMPX 35
- PCF N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- PCF Trusts Except Educational Religious and Charitable
- Sector
- CMPX Health Care
- PCF Finance
- Exchange
- CMPX Nasdaq
- PCF Nasdaq
- Market Cap
- CMPX 291.8M
- PCF 196.9M
- IPO Year
- CMPX N/A
- PCF N/A
- Fundamental
- Price
- CMPX $2.11
- PCF $6.31
- Analyst Decision
- CMPX Strong Buy
- PCF
- Analyst Count
- CMPX 8
- PCF 0
- Target Price
- CMPX $13.13
- PCF N/A
- AVG Volume (30 Days)
- CMPX 804.2K
- PCF 74.8K
- Earning Date
- CMPX 05-08-2025
- PCF 01-01-0001
- Dividend Yield
- CMPX N/A
- PCF 10.90%
- EPS Growth
- CMPX N/A
- PCF N/A
- EPS
- CMPX N/A
- PCF N/A
- Revenue
- CMPX $850,000.00
- PCF N/A
- Revenue This Year
- CMPX N/A
- PCF N/A
- Revenue Next Year
- CMPX N/A
- PCF N/A
- P/E Ratio
- CMPX N/A
- PCF N/A
- Revenue Growth
- CMPX N/A
- PCF N/A
- 52 Week Low
- CMPX $0.77
- PCF $5.71
- 52 Week High
- CMPX $4.08
- PCF $6.96
- Technical
- Relative Strength Index (RSI)
- CMPX 57.65
- PCF 50.55
- Support Level
- CMPX $2.06
- PCF $6.16
- Resistance Level
- CMPX $2.23
- PCF $6.33
- Average True Range (ATR)
- CMPX 0.12
- PCF 0.08
- MACD
- CMPX 0.01
- PCF -0.00
- Stochastic Oscillator
- CMPX 69.23
- PCF 55.48
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About PCF High Income Securities Fund
High Income Securities Fund is a closed-end management investment company. Its primary objective is to provide high current income and capital appreciation is the secondary objective. The Fund pursues its objective primarily by investing in both convertible bonds and convertible preferred stocks. The Fund also invests significantly in high-yielding non-convertible securities with the potential for capital appreciation.